<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR21">
 <label>21.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Prada</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Davis</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Jean-Pierre</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>La Roche</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Duh</surname>
    <given-names>FM</given-names>
   </name>
   <name>
    <surname>Carrington</surname>
    <given-names>M</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Drug-susceptible HIV-1 infection despite intermittent fixed-dose combination tenofovir/emtricitabine as prophylaxis is associated with low-level viremia, delayed seroconversion, and an attenuated clinical course</article-title>
  <source>J Acquir Immune Defic Syndr</source>
  <year>2008</year>
  <volume>49</volume>
  <issue>2</issue>
  <fpage>117</fpage>
  <lpage>122</lpage>
  <pub-id pub-id-type="doi">10.1097/QAI.0b013e3181869a9b</pub-id>
  <pub-id pub-id-type="pmid">18769360</pub-id>
 </element-citation>
</ref>
